Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer

Table 4 Details of recurrent cases with pT1N1 in gastric cancer

Case	Age (yr)	Sex	T depth	T size	Histology	Lauren	LVI	Number of metastatic LNs	Size of metastasis (mm)	Pattern	Location	Tumor burden (mm)	Proportion	Extent of LND	Number of dissected LNs	Site of recurrence
1	62	M	Sm3	2.3	Undiff	Diffuse	Present	2	2.3	Single cluster	Parenchyme	2.5	40.0%	D1 + β	31	N3 LN
2	62	M	Sm3	3.0	Diff	Intestinal	Present	2	3.1	Single cluster	Parenchyme	3.88	26.0%	D2	59	Liver
3	72	M	Sm3	3.0	Diff	Intestinal	Present	1	3.6	Diffuse	Diffuse	9.62	65.0%	D1 + β	14	Peritoneum
4	59	M	Sm3	3.0	Diff	Intestinal	Present	4	5.5	Single cluster	Parenchyme	10.8	45.0%	D2	45	Liver, lung
5	76	F	Sm2	5.0	Diff	Intestinal	Present	1	6.0	Single cluster	Parenchyme	6.0	67.0%	D2	54	Liver
6	58	F	Sm3	5.5	Undiff	Intestinal	Present	3	3.2	Multiple cluster	Parenchyme	7.2	87.0%	D2	43	PALN

LVI: Lymphovascular invasion; LN: Lymph node; LND: Lymph node dissection; PALN: Para-aortic lymph node; Diff: Differentiate; Undiff: Undifferentiate.